statistiche ricercatore

Continente	#
NA - Nord America	356
EU - Europa	314
AS - Asia	256
SA - Sud America	48
AF - Africa	21
Continente sconosciuto - Info sul continente non disponibili	1
Totale	996

Nazione	#
US - Stati Uniti d'America	344
IT - Italia	105
SG - Singapore	71
CN - Cina	61
DE - Germania	45
RU - Federazione Russa	44
HK - Hong Kong	42
VN - Vietnam	42
BR - Brasile	37
IE - Irlanda	35
FI - Finlandia	24
FR - Francia	14
GB - Regno Unito	13
IN - India	11
ZA - Sudafrica	10
CA - Canada	6
MX - Messico	6
NL - Olanda	6
PL - Polonia	6
SE - Svezia	6
AR - Argentina	4
JP - Giappone	4
BD - Bangladesh	3
BE - Belgio	3
MA - Marocco	3
PK - Pakistan	3
UA - Ucraina	3
VE - Venezuela	3
AT - Austria	2
CZ - Repubblica Ceca	2
ID - Indonesia	2
IQ - Iraq	2
KE - Kenya	2
LK - Sri Lanka	2
LT - Lituania	2
MU - Mauritius	2
PH - Filippine	2
TH - Thailandia	2
TN - Tunisia	2
A2 - ???statistics.table.value.countryCode.A2???	1
BA - Bosnia-Erzegovina	1
BH - Bahrain	1
CL - Cile	1
CO - Colombia	1
EC - Ecuador	1
EE - Estonia	1
ES - Italia	1
GE - Georgia	1
IL - Israele	1
IR - Iran	1
KG - Kirghizistan	1
KW - Kuwait	1
MZ - Mozambico	1
NP - Nepal	1
PS - Palestinian Territory	1
PY - Paraguay	1
RO - Romania	1
SN - Senegal	1
TR - Turchia	1
Totale	996

Nome	#
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy	146
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy	136
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy	131
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count	125
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020	112
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy	91
Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified?	79
Corrigendum to "Seroprevalence of SARS-CoV-2 in 1922 blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area" [Clin Microbiol Infect 27 (6) (2021 Jun) 914.e1-914.e4]	64
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection	62
Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area	62
Totale	1.008

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	3	0	0	0	0	0	0	0	0	0	0	3	0
2021/2022	40	2	3	3	1	2	1	3	2	1	4	2	16
2022/2023	124	6	8	2	9	6	10	0	2	42	0	37	2
2023/2024	78	10	8	3	3	7	14	4	3	0	5	12	9
2024/2025	282	4	23	4	36	5	17	21	9	58	24	24	57
2025/2026	448	36	34	65	58	47	18	88	31	49	22	0	0
Totale													1.008